Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Brain Neoplasms
×
trastuzumab deruxtecan
×
Clear all
Filters
3
NCT04739761
2026-02-11
DESTINY-B12
AstraZeneca
Phase 3
Active not recruiting
506 enrolled
27 charts